Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Geron (GERN) Cash & Equivalents: 2010-2025

Historic Cash & Equivalents for Geron (GERN) over the last 16 years, with Sep 2025 value amounting to $78.1 million.

  • Geron's Cash & Equivalents rose 29.45% to $78.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.1 million, marking a year-over-year increase of 29.45%. This contributed to the annual value of $79.0 million for FY2024, which is 12.84% up from last year.
  • Per Geron's latest filing, its Cash & Equivalents stood at $78.1 million for Q3 2025, which was up 0.49% from $77.7 million recorded in Q2 2025.
  • In the past 5 years, Geron's Cash & Equivalents ranged from a high of $189.8 million in Q1 2024 and a low of $29.0 million during Q3 2021.
  • Its 3-year average for Cash & Equivalents is $86.9 million, with a median of $78.1 million in 2025.
  • In the last 5 years, Geron's Cash & Equivalents spiked by 260.02% in 2023 and then crashed by 55.87% in 2025.
  • Over the past 5 years, Geron's Cash & Equivalents (Quarterly) stood at $34.9 million in 2021, then skyrocketed by 63.02% to $56.8 million in 2022, then rose by 23.18% to $70.0 million in 2023, then climbed by 12.84% to $79.0 million in 2024, then grew by 29.45% to $78.1 million in 2025.
  • Its Cash & Equivalents stands at $78.1 million for Q3 2025, versus $77.7 million for Q2 2025 and $83.7 million for Q1 2025.